Shailesh Chitnis

Shailesh Chitnis appears in Wake-up haul: an Ozempic moment for the brain as the The Intelligence voice explaining why Orexin Agonists have attracted post-GLP-1 attention. His segment introduces orexin as a wakefulness-related neuropeptide, then moves from Narcolepsy Wake-Sleep Boundary to possible but uncertain future uses in depression, ADHD, and addiction.

The source uses him as a cautioning expert voice. He frames the Ozempic comparison as a way to understand pharmaceutical excitement, while warning that drug discovery has many plausible ideas that never become broad commercial markets.

Connections

• The Intelligence and Economist Podcasts - show and publisher context.
• Orexin Agonists, Narcolepsy Wake-Sleep Boundary, Ovoperextone, and GLP-1 Agonists - segment themes.
• Takeda Pharmaceutical / 武田制药, Alkermes, Eli Lilly, and Sentessa Pharmaceuticals - companies named in the orexin segment.